BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11035699)

  • 21. [Treatment of ifosfamide induced encephalopathy with methylene-blue].
    Ferrero JM; Eftekari P; Largillier R; Dreyfus G; Namer M
    Bull Cancer; 1995 Jul; 82(7):598-9. PubMed ID: 7549123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ifosfamide administered according to three different schedules in metastatic soft tissue and bone sarcomas.
    Comandone A; Leone L; Oliva C; Frustaci S; Monteleone M; Colussi AM; Dal Canton O; Bergnolo P; Boglione A; Bumma C
    J Chemother; 1998 Oct; 10(5):385-93. PubMed ID: 9822357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ifosfamide].
    Manegold C
    Zentralbl Gynakol; 1996; 118(10):580-1. PubMed ID: 8999718
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I; Tekuzman G; Yalçin S; Güllü I; Güler N; Ozişik Y; Kars A; Celik I; Türker A; Altundağ K; Zengin N; Uner A; Baltali E; Firat D
    J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide induced encephalopathy in a child with osteosarcoma.
    Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
    J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
    Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
    Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.
    Filhon B; Lacarra B; Hervouet C; Jaffray M; Schneider P; Vannier JP
    Pediatr Blood Cancer; 2016 Feb; 63(2):372-3. PubMed ID: 26397980
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose finding of ifosfamide administered with a chronic two-week continuous infusion.
    Cartei G; Clocchiatti L; Sacco C; Pella N; Bearz A; Mantero J; Pastorelli D; Salmaso F; Zustovich F
    Oncology; 2003; 65 Suppl 2():31-6. PubMed ID: 14586144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin.
    Tavella K; Villanucci A; Vannini L; Lavacchi D; Montelatici S; Amunni G; Mazzei T
    Anticancer Drugs; 2017 Apr; 28(4):465-468. PubMed ID: 28181940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
    Tursz T
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
    Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
    Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible ifosfamide-induced panic attacks.
    Brahmachari B; Hazra A; Majumdar A
    J Postgrad Med; 2008; 54(4):339-40. PubMed ID: 18953166
    [No Abstract]   [Full Text] [Related]  

  • 33. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
    Goren MP; Epelman S; Bush DA
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifosfamide-induced encephalopathy.
    Gonzalez-Angulo AM; Orzano JA; Davila E
    South Med J; 2002 Oct; 95(10):1215-7. PubMed ID: 12425514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifosfamide-induced alteration of technetium-99m-DMSA renal parenchymal imaging.
    Morrison SC; O'Donnell JK
    J Nucl Med; 1997 Nov; 38(11):1811-2. PubMed ID: 9374361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
    Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
    J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients].
    Baranzelli MC; Pichon F; Gourmel B; N'Guyen M; Deligny N; Demaille MC
    Bull Cancer; 1997 Feb; 84(2):141-6. PubMed ID: 9180836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucose infusions--a possible effective therapeutic option in ifosfamide-induced encephalopathy].
    Kellner O; Dempke W; Schmoll HJ
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1086-7. PubMed ID: 10520310
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of ifosfamide encephalopathy with intravenous thiamin.
    Buesa JM; García-Teijido P; Losa R; Fra J
    Clin Cancer Res; 2003 Oct; 9(12):4636-7. PubMed ID: 14555540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.